Navigation Links
Dr. Yu Yamaguchi named recipient of the Humanitarian Scientific Achievement Award
Date:10/25/2007

Burnham Institute for Medical Research Professor Yu Yamaguchi, M.D., Ph.D., was recently awarded The Humanitarian Scientific Achievement Award by the MHE Research Foundation. The focus of the foundation is to find a cure for Multiple Hereditary Exostoses, a rare genetic bone disorder. The disorder causes people to grow exostoses (bone tumors) on their bones. MHE patients can also suffer from non-skeletal medical issues including mental and neurological issues. At this time, there is no treatment or cure. Surgery, physical therapy and pain management are currently the only options in management of the condition.

Mutations in a gene known as EXT1 cause MHE. Dr. Yamaguchi created a mouse model, in which the EXT1 gene can be experimentally disrupted in tissues and organs of interest. His research has provided insights into why MHE patients suffer from non-skeletal medical problems. Dr. Yamaguchi has recently shown that mutations in the EXT1 gene can cause dysfunction of nerve cells, providing a clue as to why MHE patients sometimes associate mental and neurological symptoms. Today, the mouse model is being used in more than 20 laboratories around the world, helping researchers explore the function of the EXT1 gene in a variety of organs and tissues.

Dr. Yu Yamaguchi has expanded the frontiers of understanding of MHE, said Sarah Ziegler, MHE Research Foundation Vice President. These insights also suggest potential novel approaches that can be explored in order to make the dream of a treatment into a reality. Ziegler is also the mother of a son with MHE.

A crystal plaque commemorating the award was presented to Dr. Yamaguchi during the Foundation's FUNTASIA Research Banquet held on September 30, 2007 in Brooklyn, New York. Dr. Yamaguchi was also presented citations and proclamations from U.S. Congress, New York State Senate, and the Borough of Brooklyn.


'/>"/>

Contact: Andrea Moser
amoser@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. UP government decides to suspend doctor named in sting operation
2. Yale Researchers Named Ellison Foundation Senior Scholars in Aging
3. Brian Lara Opens Cancer Center Named After Him
4. Bat Virus Renamed After Protests from Malaysia State
5. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
6. Kidney Donors Health Can Cause Anxiety Among Kidney Recipients
7. Kidney transplant donor and recipients need to talk it out
8. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
9. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
10. TNF Protein Can Predict GVHD Bone Marrow Transplant Recipients
11. Kidney Transplant Recipients Tardy In Taking Vital Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... Mother Nature ... grow – flowers, plants, fruits and vegetables. , Celebrate these women with more ... life, an unexpected gift with these five garden-themed options. , Vibrant, Edible, Compact ...
(Date:5/4/2016)... LIVONIA, MICH. (PRWEB) , ... May 04, 2016 ... ... offering $2 million in grants to identify, fund and implement ideas aimed at ... Medicare and Medicaid. , “Part of our vision for Trinity Health is ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... and Vancouver, WA, has announced the latest beneficiary of their ongoing community ... and their Mammography Program, which provides free mammograms and diagnostic breast care ...
(Date:5/4/2016)... ... 04, 2016 , ... The RIDER Institute announces an IndieGoGo ... broad-spectrum antiviral therapeutics. DRACOs have proven effective against all 18 viruses tested in ... http://igg.me/at/EndTheVirus and runs for 60 days, we are raising new funding ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nike Rugby Camp's success is due in large ... founder of Elite Rugby Camps and current Nike Camp director, has offered an all ... , “I’m excited for our eighth summer here in San Diego,” says Willis. ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... Jerusalem announced today that it had signed an ... Inc. , developer of novel protein degradation and immunomodulatory ... and commercialization of drug candidates representing first-in-class therapy for ... were not disclosed. The novel technology was ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Acute Myeloid Leukemia Market ... to their offering.       (Logo: ... Myeloid Leukemia Market and Competitive Landscape Highlights ... Leukemia pipeline products, Acute Myeloid Leukemia epidemiology, ...
(Date:5/3/2016)... Research and Markets has announced the addition ... Outlook 2020" report to their offering. ... has improved significantly in past years due to which ... years. Many cancer drugs have been developed by utilization ... expected to be developed with its help. They are ...
Breaking Medicine Technology: